Journal of Bioequivalence & Bioavailability

Bhaswat Chakraborty

Bhaswat Chakraborty
Senior VP, Research and Developmentm, Cadila Pharmaceuticals Ltd
India

Biography

Dr. Bhaswat S Chakraborty is currently 2005 to 2010 a Senior VP Research Development of Cadila Pharmaceuticals Ltd, Ahmedabad, Gujarat, India where he is responsible for Clinical Pharmacology Clinical Trials Ph IIV. Bioequivalence Trials Preclinical Studies Bioinformatics and Data Management. He is also an Adjunct Faculty of Albany College of Pharmacy and Health Sciences Albany New York USA; Editorial Board Member Journal of Bioequivalence Bioavailability; PhD Guide and External Examiner to a number of Universities in India. He has been a reviewer for several international journals and member of Ethics Committee and DSMB Dr Chakraborty received his PhD 1987 in Clinical Pharmacology from University of Sakatchewan, Canada. He served as a Senior Safety and Efficacy Reviewer 1989 to 1997 and Acting Division Chief at the Therapeutic Drugs Directorate Canadian FDA, Ottawa, Canada. Dr. Chakraborty also served as the Director of Biopharmaceutics 1997 to 2000 Biovail Contract Research Toronto, Canada and President of Foresee Consultant until the present assignmentHe is founder of a Spiritual Association. Dr. Chakraborty has more than 60 research papers and abstracts in peer reviewed journals. He has received many merit awards and AAPS Visiting Scientist Awards.

Research Interest

Mind-Body Medicine and Positive Mental Culture
Randomized Clinical Trials of Anticancer Drugs and Vaccines
Randomized Clinical Trials of Cardiovascular and Antidiabetic Drugs
Animal and Human Ethics
Operational Research in Clinical Trials Management
Analysis and Interpretation of Clinical Trial Data
Analysis of Biological Samples using LC-MS-MS with a special focus on Elimination or Estimation of Matrix Effects
Toxic Signal Detection by Data Mining in Pharmacovigilance.